Protease-triggered unveiling of bioactive nanoparticles. - Wikidata - awgldk - TriplyDB

Protease-triggered unveiling of bioactive nanoparticles.

Protease-triggered unveiling of bioactive nanoparticles.

http://www.wikidata.org/entity/Q37381733

about

Smart nanosystems: Bio-inspired technologies that interact with the host environment CPP-Assisted Intracellular Drug Delivery, What Is Next?Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging.Novel molecular and nanosensors for in vivo sensing Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases.Targeting of drugs and nanoparticles to tumors.Insights into atherosclerosis using nanotechnology Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors Growth factor delivery-based tissue engineering: general approaches and a review of recent developments Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia FRET-based and other fluorescent proteinase probes.siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells.Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.Biotargeted nanomedicines for cancer: six tenets before you begin Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine.Cell-penetrating peptides: achievements and challenges in application for cancer treatment.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Strategies for in vivo imaging of enzyme activity: an overview and recent advances.Cell-penetrating peptides: A tool for effective delivery in gene-targeted therapies.Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.Applying nanomedicine in maladaptive inflammation and angiogenesis.Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.Controlled apoptosis by a thermally toggled nanoscale amplifier of cellular uptake.Nanoparticle-based probes to enable noninvasive imaging of proteolytic activity for cancer diagnosis.Strategies for improving drug delivery: nanocarriers and microenvironmental priming.In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery.Oligonucleotide delivery by cell-penetrating "striped" nanoparticles.Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.Enzymatic activity inside a DNA/peptide complex.Effect of partial PEGylation on particle uptake by macrophages.Sustained-release synthetic biomarkers for monitoring thrombosis and inflammation using point-of-care compatible readouts.Oligonucleotide Delivery by Cell-Penetrating “Striped” Nanoparticles Retinoic Acid Decorated Albumin-Chitosan Nanoparticles for Targeted Delivery of Doxorubicin Hydrochloride in Hepatocellular Carcinoma

P2860

Q26776370-9BF6CE2B-00E8-4D02-9780-59B4493E8C97 Q28079386-1D92DA7D-DF22-485C-8CE9-8FD6DBD7DE96 Q30446764-98211DDD-CC58-4BF3-9DAD-6CA51E6F1CEB Q30450856-10C92D6F-1E56-4DA2-855F-AB1FFACB74EB Q33733160-C86DEA1F-E3CA-4EC1-8FE4-07346056A7C7 Q33751710-D91CCFE4-5B23-4781-9B38-0D9C1CBF842D Q33824820-7C7C7B10-635C-4914-8D64-4107B0276D95 Q33839384-5DE9A167-2D2B-42C4-8552-1961951D19B8 Q33855309-02B166F9-35BD-4864-9472-72B1E4907639 Q34548765-1D31E87F-8526-4547-BE43-B761B3463C5A Q34675546-38965501-4AE3-4033-BAC2-13929FB6483D Q35074580-C09CBEE5-62F5-4316-A13B-B936F3D4AC78 Q35086168-ED953DC3-C1EB-4D2F-AD96-E8D2ABD2D93C Q35207239-33C306B8-DA7A-469F-8AE4-33E18225F1B2 Q35783096-24576E56-DCA0-44C2-AE14-4ACA95396463 Q36612939-DB3853B5-1332-48E9-A7E3-A97B9AB15046 Q36814280-E61B3EAB-81ED-4F9E-80ED-80CB7CDD73D2 Q36854231-14E3FCEA-CF2D-470B-8028-A02BC88F8354 Q37462618-829241FD-AFFA-43DC-9A97-FEB4F9D613FC Q37594526-0086EBA3-7CAB-41E5-850B-DDD5216D4B37 Q37775972-5B9920E1-8724-4572-861E-30BFC017CDE3 Q37873318-89CF9560-F276-4AE2-9E35-E0BAB8C4DC7A Q38198590-07B115E6-CC3A-49A6-B12D-52D42CEF4023 Q38235410-6CB75126-7B2E-418F-B44E-379F173C15E5 Q38557650-63DB228E-A16B-4CC8-AA9C-B5A478C88CDC Q38658534-E2D0889F-FAC7-4F68-B131-1D5B171AA97C Q38740666-073CB63C-C166-4C3A-9F56-0AA515EC64D0 Q38837131-086F8083-F8F8-4D0B-88E3-536ADE92DA06 Q38968910-35DB10C6-3C79-4D96-A629-6999851B12C5 Q39761175-CDD3F23E-2DBD-45B4-9806-DB772BA0C33C Q42077942-4D63C124-E30E-4FE9-9DEE-EA8A53357A24 Q42080674-DA3D85D6-75C7-421B-AFB5-25EC0E1B5503 Q42145728-DCAD84F9-8A34-423C-9FB4-6E9837916D46 Q47794660-8C7A6B7C-554D-4879-AA21-CDF1345B09E5 Q48916206-1368CA9C-927C-49FD-A4DD-757A0E13461B Q54606553-8BF1A88E-44DD-4FBC-860F-572B713B2D60 Q57910117-EA2C081A-40E4-41C9-976D-3196440AD653 Q59016832-4A316692-670D-480E-830B-21F7EB5520CF

P2860

Protease-triggered unveiling of bioactive nanoparticles.

http://www.wikidata.org/entity/Q37381733

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Protease-triggered unveiling of bioactive nanoparticles.

@en

Protease-triggered unveiling of bioactive nanoparticles.

@nl

type

label

Protease-triggered unveiling of bioactive nanoparticles.

@en

Protease-triggered unveiling of bioactive nanoparticles.

@nl

prefLabel

Protease-triggered unveiling of bioactive nanoparticles.

@en

Protease-triggered unveiling of bioactive nanoparticles.

@nl

P1433

Q37381733-0CF46BDD-56F5-4874-87A1-1FD6407A0178

P1476

Q37381733-1F2B8D78-9326-4FB1-AEA8-1D42BABFC8B8

P2093

Q37381733-298ABEED-001C-47B4-A954-77A316FBF73B

Q37381733-6B585741-3A2D-4531-9B4D-8E4602A4E163

Q37381733-6C2D88DC-F40F-423D-AF86-3834040DC0CE

Q37381733-761035E5-3AB7-4E70-A088-C829CB4009D4

Q37381733-A93FB903-BB4B-47CC-BA0C-E4996B63F934

Q37381733-C89ED701-533B-463C-B560-9F337703B3F2

Q37381733-C9FC16D2-D2E7-4D44-A5F0-55EDEF1A1E5C

Q37381733-FDB3678F-4070-4043-B404-77DDE6F0A422

P2860

Q37381733-1D21C8A1-48CD-4B66-95AD-A68AAFCC8AB1

Q37381733-3EFA3F40-52C7-4A81-A454-AB853A789E04

Q37381733-4E8E08E9-D6BE-4AC6-876B-5FAAC0728948

Q37381733-51E19B76-66F6-4676-931C-A215D5EC6C94

Q37381733-5474749A-52AF-414A-9525-8FD625AD96DE

Q37381733-6D2E8E07-EAE4-4874-9620-77566B5F5C97

Q37381733-7B9C9F6A-3851-4D67-84B0-A4842DB084EE

Q37381733-7DD7FECE-4E1B-4C96-9FA8-502F999E0247

Q37381733-824E46F2-5BC4-4C16-9BDC-E36AD3BF9E43

Q37381733-874ECEB2-DF3F-465D-A3B6-6BA726F70B83

P304

Q37381733-07CA4BB5-C9EE-41C2-B60C-90C740AA7D05

P31

Q37381733-AD2CB0B0-EC01-4E81-98C5-F3F11C2A0F7D

P356

Q37381733-C779B45F-9D36-4BB0-A1DE-97EB45F193D7

P433

Q37381733-A69DA129-DA42-4CB8-A587-7AC6FFEED104

P478

Q37381733-B1FC8B25-1206-4049-AAFB-6B18094817D2

P577

Q37381733-64A5DD5D-AF43-4373-A849-25B32CA07828

P5875

Q37381733-4CA1FCDE-0256-4F66-83EB-BFD538BB142C

P698

Q37381733-6A8BDC7E-0F2C-4F59-BEFC-17F9ED57EA7E

P921

Q37381733-75B7175B-5427-4C0B-9446-59B4605C8BC1

P932

Q37381733-7F58CBAF-BB0B-45E0-BE1F-A01020DDA8C0

P356

P1433

P1476

Protease-triggered unveiling of bioactive nanoparticles.

@en

P2093

Amit Agrawal

http://www.w3.org/2001/XMLSchema#string

Dal-Hee Min

http://www.w3.org/2001/XMLSchema#string

Geoffrey von Maltzahn

http://www.w3.org/2001/XMLSchema#string

Ji-Ho Park

http://www.w3.org/2001/XMLSchema#string

Matthew E Lord

http://www.w3.org/2001/XMLSchema#string

Michael J Sailor

http://www.w3.org/2001/XMLSchema#string

Sangeeta N Bhatia

http://www.w3.org/2001/XMLSchema#string

Todd J Harris

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

Drug-polymer conjugates containing acid-cleavable bonds.

In vivo molecular target assessment of matrix metalloproteinase inhibition.

Long-circulating and target-specific nanoparticles: theory to practice.

Multifunctional nanocarriers.

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

On the formulation of pH-sensitive liposomes with long circulation times.

Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

P304

1307-1312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SMLL.200701319

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23159348

http://www.w3.org/2001/XMLSchema#string

P698

18690639

http://www.w3.org/2001/XMLSchema#string

P921

P932

2759667

http://www.w3.org/2001/XMLSchema#string